Predictors of clozapine discontinuation at 2 years in treatment-resistant schizophrenia

Simple item page
dc.catalogadorjwg
dc.contributor.authorIruretagoyena Bruce Barbara Arantzazu
dc.contributor.authorCastañeda, Carmen Paz
dc.contributor.authorMena, Cristian
dc.contributor.authorDiaz, Camila
dc.contributor.authorNachar, Ruben
dc.contributor.authorRamirez Mahaluf Juan Pablo
dc.contributor.authorGonzález Valderrama, Alfonso
dc.contributor.authorUndurraga, Juan
dc.contributor.authorMaccabe, James H
dc.contributor.authorCrossley, Nicolas A
dc.date.accessioned2024-06-05T13:21:10Z
dc.date.available2024-06-05T13:21:10Z
dc.date.issued2021
dc.description.abstractLittle is known about predictors of clinical response to clozapine treatment in treatment-resistant psychosis. Most published cohorts are small, providing inconsistent results. We aimed to identify baseline clinical predictors of future clinical response
dc.description.funderAgencia Nacional de Investigacion y Desarrollo from Chile (ANID), through its programs ANILLO PIA
dc.description.funderFONDECYT
dc.fechaingreso.objetodigital2024-12-09
dc.fuente.origenORCID
dc.identifier.doi10.1016/j.schres.2021.07.024
dc.identifier.eissn1573-2509
dc.identifier.pubmedidMEDLINE:34340062
dc.identifier.urihttps://kclpure.kcl.ac.uk/ws/files/206128605/Iruretagoyena_et_al_2021.pdf
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/86417
dc.identifier.wosidWOS:000689657400019
dc.information.autorucEscuela de Medicina; Crossley Karmelic, Nicolas Andres; 0000-0002-3060-656X; 11224
dc.information.autorucEscuela de Medicina; Iruretagoyena Bruce Barbara Arantzazu; S/I; 164907
dc.information.autorucEscuela de Medicina; Ramirez Mahaluf Juan Pablo; 0000-0002-0821-1174; 17132
dc.language.isoen
dc.nota.accesoContenido parcial
dc.pagina.final108
dc.pagina.inicio102
dc.publisherELSEVIER
dc.revistaSCHIZOPHRENIA RESEARCH
dc.rightsacceso restringido
dc.subjectAdherence
dc.subjectAntipsychotic
dc.subjectTreatment
dc.subjectClozapine
dc.subjectDuration Guidelines
dc.subjectMedication
dc.subjectNationwide
dc.subjectSchizophrenia
dc.subjectTreatment-delay
dc.subjectTreatment-resistant psychosis
dc.subjectUntreated Psychosis
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.ods03 Good health and well-being
dc.subject.odspa03 Salud y bienestar
dc.titlePredictors of clozapine discontinuation at 2 years in treatment-resistant schizophrenia
dc.typeartículo
dc.volumen235
sipa.codpersvinculados11224
sipa.codpersvinculados164907
sipa.codpersvinculados17132
sipa.trazabilidadORCID;2024-06-03
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Predictors of clozapine discontinuation at 2 years in treatmentresistant schizophrenia.pdf
Size:
91.5 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas